Dr. Andrew Keegan of the Roskamp Institute tests new Alzheimer's disease drug

Rather than the common amyloid or tau protein directed therapies, the one Dr. Andrew Keegan is testing "feeds" the brain more energy to try to overcome dementia. RICHARD DYMOND/Bradenton Herald
Up Next
Rather than the common amyloid or tau protein directed therapies, the one Dr. Andrew Keegan is testing "feeds" the brain more energy to try to overcome dementia. RICHARD DYMOND/Bradenton Herald

Manatee scientist exploring new approach to treating Alzheimer's

March 14, 2016 04:56 PM